BERLIN, April 2, 2011 /PRNewswire/ --
- Well-Known Drug Provides New Hope for Difficult to Treat Liver Cancer
Patients
Thalidomide has shown potential to be used as the first adjuvant therapy
for hepatocellular carcinoma (HCC), according to data presented at the
International Liver Con